Combining cabozantinib, nivolumab and ipilimumab in advanced hepatocellular carcinoma: does benefit outweigh toxicity?
@article{CCO120937, author = {Thiago A. Miranda and Daniel M. Girardi and Allan A. L. Pereira}, title = {Combining cabozantinib, nivolumab and ipilimumab in advanced hepatocellular carcinoma: does benefit outweigh toxicity?}, journal = {Chinese Clinical Oncology}, volume = {13}, number = {3}, year = {2024}, keywords = {}, abstract = {}, issn = {2304-3873}, url = {https://cco.amegroups.org/article/view/120937} }